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Abstract: Eighteen (2RS,6RS)-2-(4-methoxyphenyl)-6-(substituted ethyl)dihydro-2H-
pyran-4(3H)ones were synthesized via a DDQ-mediated oxidative carbon-hydrogen bond 
activation reaction. Fourteen of these tetrahydropyrans were substituted with triazoles 
readily assembled via azide-alkyne click-chemistry reactions. Examples of a linked 
benzotriazole and pyrazole motif were also prepared. To complement the structural 
diversity, the alcohol substrates were obtained from stereoselective reductions of the 
tetrahydropyrone. This library provides rapid access to structurally diverse non-natural 
compounds to be screened against a variety of biological targets. 
Keywords: Tetrahydropyran; C-H activation; click-chemistry; diversity-oriented synthesis 
 
1. Introduction  
Natural products and their derivatives continue to provide innovative sources for drug discovery  
[1-4]. However, many naturally occurring substrates appear to selectively target more highly 
connected networks associated with essential biological pathways [5,6]. The aims of the NIH 
supported Centers for Methodology and Library Design (CMLDs) are to produce diverse chemical 
libraries using novel synthetic methodologies [7]. These non-natural compound collections are 
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delivered to High Throughput Screening (HTS) centers for biological evaluation. Novel chemical 
scaffolds (i.e., chemotypes) can provide opportunities to investigate biological targets or pathways that 
may be inaccessible using only the array of currently known natural products, clinically used 
compounds, or traditional (hetero)aromatic building blocks. In this communication, we describe  
our diversity-oriented synthesis (DOS) approach to generate a structurally diverse set of  
triazole-substituted tetrahydropyrans [8,9]. The chemical diversity of these compounds was evaluated 
against a 5 million “drug-like” compound database (vide infra).  
Tetrahydropyrans are important structural motifs found in a wide array of natural products, from 
glucose and centrolobine [10-12] to structurally elaborate metabolites such as neopeltolide [13-15] 
leucascandrolide A [16] phorboxazole A and B [17,18] and the even more complex architectures 
present in palytoxin, maitotoxin, and other marine natural products (Figure 1) [19,20].  
Figure 1. Examples of natural products with a tetrahydropyran core unit. 
 
 
We have recently demonstrated that tetrahydropyrans (THPs) can be formed in high 
diastereocontrol from benzylic and allylic ethers through a DDQ-mediated (2,3-dichloro-5,6-dicyano-
1,4-benzoquinone) oxocarbenium ion formation followed by an intramolecular nucleophilic  
addition [21,22]. This versatile methodology is both step [23] and atom[24] efficient, and has been 
successfully applied to a series of THP-containing natural products [25-28]. This approach can 
generate a variety of functionalized THP ring systems and allow for rapid side chain diversification. 
This report will focus on the construction of triazole- (and related heterocyclic) tethered 
tetrahydropyrones using azide-alkyne ‘click’ chemistry [29,30].  
2. Results and Discussion  
The p-methoxybenzyl (PMB) ether 1 was converted into the substituted tetrahydropyrone 2 using 
our DDQ-mediated oxidative cyclization protocol [21,22]. The corresponding azide intermediate 3 was 
synthesized using standard conversions. A stepwise copper (I)-catalyzed Huisgen cycloaddition 
process was used to couple 3 with various terminal acetylenes to afford the 1,4-disubstituted 1,2,3-
triazoles 4-17 (Scheme 1 and Table 1) [29,30]. The alkynes were selected to produce a series of 
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structurally diverse triazoles, all of which gave acceptable calculated physiochemical properties 
including clogP values [31,32]. Protodesilylation of analog 6 with TBAF and acetic acid furnished the 
unsubstituted triazole 6 in 29% yield over two steps. 
Scheme 1. Preparation of triazoles 4-17.  
 
Conditions: a. TBAF, THF, r.t., 92%; b. MsCl, TEA, DMAP, DCM; c. NaN3, DMF, , 85% (2 steps). 
Table 1. Tetrazoles 4-16.  
Compound number R Yield (%) clogP 
4 Ph 71 3.8 
5 SiMe3 54 3.8 
6 H 29 (two steps) 2.0 
7 Me 55 2.4 
8 iPr 46 3.2 
9 
 
72 4.0 
10 
 
92 3.9 
11 
 
86 3.1 
12 
 
83 2.7 
13 
 
28 2.7 
14 
 
87 2.6 
15 
 
86 4.0 
16 
 
84 4.1 
17 
 
82 4.5 
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In order to further expand the chemical diversity within this series, a few additional non-triazole 
containing products were prepared (Scheme 2). The azide intermediate 3 underwent cycloaddition with 
benzyne (generated in situ from o-TMS-phenyl triflate) to provide the benzotriazole 18 [33,34]. An 
additional example involved the synthesis of the pyrazole derivative 19 that was formed from the 
displacement of the corresponding mesylate in 2a.  
Scheme 2. Additional heterocyclic substitutions of the core THP system. 
 
 
A final stereochemical diversity element was incorporated through the preparation of the syn- and 
anti-tetrahydropyranols, 20 and 21 (Scheme 3). We have previously accomplished stereoselective 
ketone reductions of similar 2,6-disubstituted tetrahydropyrones through the use of L-Selectride or 
NaBH4.[27] Thus, the 4-phenyltriazole 4 was further elaborated to selectively afford the alcohols 20 
and 21.  
Scheme 3. Preparation of alcohols.  
 
Conditions: a. NaBH4, MeOH, −10 °C, 72% (for 20); b. L-Selectride, THF, −90 °C, 92% (for 21). 
 
With the completion of the triazole and the corresponding heterocycles library, a diversity analysis 
of the 18 THP products was performed against a set of 5 million commercially available, “drug-like” 
compounds [35] using the cheminformatics package Canvas [36] and MOLPRINT2D [37,38] hashed 
binary fingerprints (32-bit, no scaling) with the default Mol2 atom types. This combination of 
fingerprint and atom type was chosen because it provides the best overall results for virtual screening 
enrichment across a wide range of targets [39,40]. Using the Tanimoto similarity metric, the 
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tetrahydropyrans described herein were found to be highly diverse compaired to the 5 million drug-like 
compounds (Figure 2). The average maximum similarity for the 18 products to any member of the 5 
million compound database is 0.41, which is remarkably low considering the large number of 
compounds in the latter repository. The highest similarity is 0.55 (observed for 4, which along with 18 
shows the highest similarity to the 5 million compound set). The least similar compound is 14, which 
has a maximum similarity to any one of the 5 million compounds of only 0.27. Figure 2 shows the 
distribution of similarities between each of the 5 million compounds and the one compound of the 18 
THPs that in each case is most similar. The figure shows that a large majority of the 5 million  
“drug-like” compounds is highly dissimilar to the 18 THPs.  
Figure 2. Distribution of similarities between 5 million drug-like, commercially available 
compounds and the most similar tetrahydropyrans.  
 
3. Experimental Section  
3.1. General 
 
All reactions were performed under an argon atmosphere and all glassware was flame dried prior to 
use. CH2Cl2 and THF were dried by passing through a column of activated alumina. Reactions carried 
out at −78 °C employed a CO2/acetone bath. Reactions were monitored by TLC analysis (pre-coated 
silica gel 60 F254 plates, 250 μm layer thickness) and visualization was accomplished with a 254 nm 
UV light and by staining with a KMnO4 solution (1.5 g of KMnO4 and 1.5 g of K2CO3 in 100 mL of a 
0.1% NaOH solution), CAM solution (5 g of cerium sulfate, 25 g of ammonium molybdate, 50 mL of 
conc. H2SO4 and 450 mL of H2O, p-anisaldehyde solution (2.5 mL of p-anisaldehyde, 2 mL of AcOH, 
and 3.5 mL of conc. H2SO4 in 100 mL of 95% EtOH). Purifications by chromatography were 
performed using SiO2 (SiliaFlash® F60, Silicycle). 1H-NMR spectra were recorded on Bruker Avance 
300/400/600 MHz instruments in CDCl3. Chemical shifts were reported in parts per million with the 
residual solvent peak used as an internal standard.  Chemical shifts are tabulated as follows: chemical 
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shift, multiplicity (s = singlet, d = doublet, t = triplet, q = quartet, m = multiplet, bs = broad singlet,  
dd = doublet of doublet, dt = doublet of triplet, dq = doublet of quartet, sp = septet), coupling 
constant(s), and integration. 13C NMR spectra were run at 75 or 100 MHz using a proton-decoupled 
pulse sequence with a d1 of 3 sec, and are tabulated by observed peak. Mass spectra were obtained on 
a Micromass Autospec double focusing instrument. IR spectra were obtained on a Identify  
IR-ATR spectrometer. 
 
(2RS,6RS)-2-(2-Hydroxyethyl)-6-(4-methoxyphenyl)dihydro-2H-pyran-4(3H)-one. To a solution of 
(2RS,6RS)-2-(2-((tert-butyldimethylsilyl)oxy)ethyl)-6-(4-methoxyphenyl)dihydro-2H-pyran-4(3H)-one 
2 [21] (0.104 g, 0.285 mmol) in THF (3.5 mL) was added TBAF (0.429 mL, 1 M solution in THF) 
dropwise at 0 °C over 10 min. The reaction mixture was allowed to warm to r.t. and stirred for 1.5 h, 
quenched with water (5 mL), extracted with DCM, dried (Na2SO4), filtered, concentrated under 
reduced pressure, and purified by chromatography (SiO2) eluting with hexane-ethyl acetate (3:7) to 
afford the primary alcohol (0.065 g, 92%) as a colorless oil: IR (neat) 3419, 2954, 2915, 1711, 1610, 
1513, 1461, 1302, 1245, 1174, 1149, 1031, 826 cm−1; 1H-NMR (300 MHz, CDCl3) δ 7.29 (d,  
J = 8.4 Hz, 2H), 6.92 (d, J = 8.7 Hz, 2H), 4.65 (t, J = 7.2 Hz, 1H), 4.07–4.03 (m, 1H), 3.86 (q,  
J = 6.0 Hz, 2H), 3.82 (s, 3H), 2.61 (d, J = 7.8 Hz, 2H), 2.48 (d, J = 7.8 Hz, 2H), 2.21 (t, J = 5.1 Hz, 
1H), 2.07–1.97 (m, 1H), 1.95–1.85 (m, 1H); 13C-NMR (75 MHz, CDCl3) δ 206.5, 159.7, 132.8, 127.2, 
114.3, 78.9, 60.5, 55.6, 55.5, 49.6, 47.9, 38.7; HRMS (ESI) m/z calcd for C14H18O4Na (M+Na) 
273.1103, found 273.1118.  
 
(2RS,6RS)-2-(2-Azidoethyl)-6-(4-methoxyphenyl)dihydro-2H-pyran-4(3H)-one (3). To a solution of the 
alcohol intermediate (0.122 g, 0.487 mmol), triethylamine (0.103 mL, 0.731 mmol) and DMAP  
(0.003 g, 0.025 mmol) in DCM (2.5 mL) was added methanesulfonyl chloride (0.045 mL,  
0.576 mmol) dropwise at 0 °C. The resulting solution was stirred at r.t. for 15 min. The reaction 
mixture was diluted with HCl (0.5 M) and extracted with DCM.  The aqueous layer was back extracted 
with DCM. The combined organic layers were washed with saturated NaHCO3, brine, dried (Na2SO4), 
filtered and concentrated under reduced pressure to obtain the crude 2-((2RS,6RS)-6-(4-
methoxyphenyl)-4-oxotetrahydro-2H-pyran-2-yl)ethyl methanesulfonate 2a (0.171 g) as a yellow oil 
which was used without further purification: 1H-NMR (400 MHz, CDCl3) δ 7.29 (d, J = 8.4 Hz, 2H), 
6.92 (d, J = 8.4 Hz, 2H,), 4.63 (dd, J = 4.4, 9.6 Hz, 1H), 4.51–4.45 (m, 1H), 4.42–4.38 (m, 1H),  
4.01–3.95 (m, 1H), 3.83 (s, 3H), 2.98 (s, 3H), 2.63-2.59 (m, 2H), 2.52-2.38 (m, 2H), 2.12-2.07  
(m, 2H). To a solution of 2a (0.171 g, 0.520 mmol) in DMF (1 mL) was added sodium azide (0.063 g,  
0.969 mmol) at r.t. The reaction mixture was stirred at r.t. for 13.5 h. TLC analysis indicated remaining 
starting material. The reaction mixture was then heated at 40 °C for 6 h and at 50 °C for 1 h, diluted 
with water, extracted with diethyl ether, dried (Na2SO4), filtered, concentrated under reduced pressure 
and purified by chromatography on SiO2 (hexane/EtOAc, 3:7) to afford the azide 3 (0.114 g, 85% over 
two steps) as a colorless oil: IR (neat) 3424, 2098, 1717, 1614, 1515, 1461, 1355, 1303, 1247, 1177, 
1032 cm−1; 1H-NMR (300 MHz, CDCl3) δ 7.29 (d, J = 8.7 Hz, 2H), 6.92 (d, J = 8.7 Hz, 2H), 4.62 (dd, 
J = 4.8, 9.6 Hz, 1H), 3.94–3.86 (m, 1H), 3.81 (s, 3H), 3.55–3.46 (m, 2H), 2.65–2.58 (m, 2H),  
2.50–2.35 (m, 2H), 1.99–1.85 (m, 2H); 13C-NMR (100 MHz, CDCl3) δ 206.2, 159.5, 132.7, 127.1, 
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114.0, 78.3, 74.1, 55.3, 49.2, 47.6, 47.5, 35.6; MS (EI) m/z 275 (M+, 25%), 135 (100); HRMS (EI) m/z 
calcd for C14H17N3O3 275.1269, found 275.1265.  
(2RS,6RS)-2-(4-Methoxyphenyl)-6-(2-(4-phenyl-1H-1,2,3-triazol-1-yl)ethyl)dihydro-2H-pyran-4(3H)-
one (4). To a suspension of 3 (0.114 g, 0.414 mmol) and phenylacetylene (0.045 mL, 0.410 mmol) in a 
mixture of water and tert-butyl alcohol (1:1, 1.7 mL) was added sodium ascorbate (0.032 mL, 1 M 
solution in water), followed by copper(II) sulfate pentahydrate (0.001 g, 0.004 mmol). The 
heterogeneous mixture was stirred at r.t. for 33 h, recharged with phenylacetylene (0.090 mL, 0.820 mmol) 
and stirred at r.t. for 21 h. The reaction mixture was diluted with water (7 mL), cooled in ice bath, and 
filtered. The precipitate was dissolved in ethyl acetate and chloroform, dried (Na2SO4), filtered, and 
concentrated to afford the corresponding triazole 4 (0.110 g, 71%) as an off-white solid: m.p. 151–152 °C; 
IR (neat) 3089, 2964, 1714, 1611, 1515, 1470, 1355, 1242, 1174, 1036, 816, 769 cm−1; 1H-NMR (300 
MHz, CDCl3) δ 7.77 (d, J = 6.9 Hz, 2H), 7.72 (s, 1H), 7.42 (t, J = 6.9 Hz, 2H), 7.35–7.32 (m, 1H), 
7.29 (d, J = 8.7 Hz, 2H), 6.91 (d, J = 8.7 Hz, 2H), 4.62–4.54 (m, 3H), 3.81 (s, 3H), 3.79–3.72 (m, 1H), 
2.59 (d, J = 7.5 Hz, 2H), 2.45–2.42 (m, 2H), 2.32–2.25 (m, 2H); 13C-NMR (75 MHz, CDCl3) δ 205.7, 
159.7, 147.8, 132.6, 130.7, 128.9, 128.3, 127.3, 125.8, 120.3, 114.3, 78.7, 74.2, 55.5, 49.3, 47.4, 46.9, 
36.6; HRMS (ESI) m/z calcd for C22H23N3O3Na (M+Na) 400.1637, found 400.1642.  
(2RS,6RS)-2-(4-Methoxyphenyl)-6-(2-(4-(trimethylsilyl)-1H-1,2,3-triazol-1-yl)ethyl)dihydro-2H-pyran-
4(3H)-one (5). To a suspension of 3 (0.072 g, 0.262 mmol) and trimethylsilylacetylene (0.075 mL, 
0.529 mmol) in a mixture of water and tert-butyl alcohol (1:1, 1.1 mL) was added sodium ascorbate 
(0.025 mL, 1 M solution in water) followed by copper(II) sulfate pentahydrate (0.001 g, 0.004 mmol). 
The heterogeneous mixture was stirred at r.t. for 14 h, recharged with trimethylsilylacetylene  
(0.075 mL, 0.529 mmol) and stirred at r.t. for an additional 6 h. The reaction mixture was diluted  
with water, extracted with diethyl ether, dried (Na2SO4), filtered, concentrated and purified by 
chromatography (SiO2) eluting with hexane-ethyl acetate (1:1) to obtain the triazole 5 (0.053 g, 54%) 
as a colorless oil: IR (neat) 2958, 1717, 1614, 1515, 1463, 1351, 1248, 1177, 1035, 839, 752 cm−1; 1H-
NMR (300 MHz, CDCl3) δ 7.46 (s, 1H), 7.31 (d, J = 8.7 Hz, 2H), 6.93 (d, J = 8.7 Hz, 2H), 4.61–4.51 
(m, 3H), 3.83 (s, 3H), 3.75–3.65 (m, 1H), 2.61–2.58 (d, J= 7.2 Hz, 2H), 2.43–2.39 (m, 2H), 2.32–2.19 
(m, 2H), 0.30 (s, 9H); 13C-NMR (75 MHz, CDCl3) δ 205.9, 159.8, 146.7, 132.7, 129.5, 127.3, 114.3, 
78.7, 74.0, 55.5, 49.4, 47.5, 46.1, 36.8, −0.9; HRMS (ESI) m/z calcd for C19H27N3O3Si Na (M+Na) 
396.1719, found 396.1698.  
 
(2RS,6RS)-2-(2-(1H-1,2,3-Triazol-1-yl)ethyl)-6-(4-methoxyphenyl)dihydro-2H-pyran-4(3H)-one (6). 
To a solution of 5 (0.050 g, 0.134 mmol) in THF (1.5 mL) was added TBAF (0.402 ml, 1 M solution in 
THF) dropwise at 0 °C followed by the addition of acetic acid (0.008 mL, 0.140 mmol). The reaction 
mixture was stirred at r.t. for 14 h, recharged with acetic acid (0.016 mL, 0.280 mmol) and stirred at 
r.t. for 4 h, concentrated, and purified by chromatography (SiO2) eluting with hexane-ethyl acetate 
(3:7) to afford 6 (0.021 g, 53%) as a colorless oil. IR (neat) 2958, 1713, 1611, 1585, 1514, 1446, 1303, 
1247, 1176, 1029, 813 cm−1; 1H-NMR (400 MHz, CDCl3) δ 7.68 (s, 1H), 7.51 (s, 1H), 7.30 (d,  
J = 8.8 Hz, 2H), 6.94 (d, J = 8.8 Hz, 2H), 4.62–4.54 (m, 3H), 3.83 (s, 3H), 3.72–3.65 (m, 1H), 2.61 (d, 
J= 8.8 Hz, 2H), 2.45–2.37 (m, 2H), 2.31–2.21 (m, 2H); 13C-NMR (100 MHz, CDCl3) δ 205.7, 159.8, 
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133.9, 132.6, 127.3, 123.9, 114.3, 78.7, 73.9, 55.5, 49.4, 47.4, 46.6, 36.7, 29.9; HRMS (ESI) m/z calcd 
for C16H20N3O3 (M+H+) 302.1505, found 302.1531. 
(2RS,6RS)-2-(4-Methoxyphenyl)-6-(2-(4-methyl-1H-1,2,3-triazol-1-yl)ethyl)dihydro-2H-pyran-4(3H)-
one (7). Propyne (1 mL, 17.7 mmol) was condensed into a 10 mL flask using a dry-ice/acetone 
condenser. A suspension of 3 (0.060 g, 0.218 mmol) in a mixture of water and tert-butyl alcohol (1:1, 
1.7 mL) was added to the flask, followed by the addition of sodium ascorbate (0.02 mL, 1 M solution 
in water), and copper(II) sulfate pentahydrate (0.001 g, 0.004 mmol). The reaction mixture was stirred 
at r.t. for 19 h, diluted with water, extracted with ethyl acetate, dried (Na2SO4), filtered, concentrated 
and purified by chromatography (SiO2) eluting with hexane-ethyl acetate (2:3) to obtain the triazole 7 
(0.038 g, 55%) as a colorless oil: IR (neat) 3584, 2956, 1715, 1612, 1514, 1303, 1247, 1176, 1049, 
1029, 813 cm−1; 1H-NMR (300 MHz, CDCl3) δ 7.29 (d, J = 8.7 Hz, 2H), 7.22 (s, 1H), 6.93 (d, J = 8.7 Hz, 
2H), 4.59–4.49 (m, 3H), 3.83 (s, 3H), 3.74–3.66 (m, 1H), 2.60–2.57 (m, 2H), 2.42–2.39 (m, 2H), 2.32 
(s, 3H), 2.27–2.22 (m, 2H); 13C-NMR (100 MHz, CDCl3) δ 205.9, 159.7, 143.5, 132.7, 127.3, 121.7, 
114.2, 78.6, 73.9, 55.5, 49.4, 47.4, 46.5, 36.8, 10.9; MS (EI) m/z 338 (M+Na, 100%), 316 (M+H, 18), 
298 (18), 233 (50), 215 (75); HRMS (ESI) m/z calcd for C17H21N3O3Na (M+Na) 338.1481, found 
338.1487.  
 
(2RS,6RS)-2-(2-(4-Isopropyl-1H-1,2,3-triazol-1-yl)ethyl)-6-(4-methoxyphenyl)dihydro-2H-pyran-4(3H)-
one (8). To a suspension of 3 (0.088 g, 0.319 mmol) and 3-methyl-1-butyne (0.065 mL,  
0.635 mmol) in a mixture of water and tert-butyl alcohol (1:1, 1.1 mL) was added sodium ascorbate 
(0.03 mL, 1 M solution in water), followed by copper(II) sulfate pentahydrate (0.001 g, 0.004 mmol). 
The heterogeneous mixture was stirred at r.t. for 18 h, diluted with water, extracted with ethyl acetate, 
dried (Na2SO4), filtered, concentrated and purified by chromatography (SiO2) eluting with  
hexane-ethyl acetate (1:1) to obtain the triazole 8 (0.050 g, 46%) as an off-white solid: m.p. 66–67 °C; 
IR (neat) 3629, 2960, 1715, 1514, 1446, 1245, 1176, 1045, 813 cm-1; 1H-NMR (300 MHz, CDCl3) δ 
7.30 (d, J = 8.7 Hz, 2H), 7.21 (s, 1H), 6.93 (d, J = 8.7 Hz, 2H), 4.58–4.49 (m, 3H), 3.82 (s, 3H),  
3.76–3.65 (m, 1H), 3.06 (sp, J = 6.9 Hz, 1H), 2.59 (d, J= 7.5 Hz, 2H), 2.42–2.39 (m, 2H), 2.28–2.19 
(m, 2H), 1.27 (dd, J = 1.8, 6.9 Hz, 6H); 13C-NMR (75 MHz, CDCl3) δ 205.9, 159.7, 154.7, 132.7, 
127.3, 119.8, 114.2, 78.7, 74.0, 55.5, 49.4, 47.4, 46.5, 36.7, 25.9, 22.7; MS (EI) m/z 366 (M+Na, 
100%), 344 (M+H, 55), 326 (40), 233 (50), 215 (60); HRMS (ESI) m/z calcd for C19H26N3O3 344.1974 
(M+H), found 344.1960.  
 
(2RS,6RS)-2-(2-(4-(4-Fluorophenyl)-1H-1,2,3-triazol-1-yl)ethyl)-6-(4-methoxyphenyl)dihydro-2H-pyran-
4(3H)-one (9). To a suspension of 3 (0.052 g, 0.189 mmol) and 1-ethynyl-4-fluorobenzene (0.043 mL, 
0.37 mmol) in a mixture of water and tert-butyl alcohol (1:1, 1.1 mL) was added sodium ascorbate 
(0.02 mL, 1 M solution in water), followed by copper(II) sulfate pentahydrate (0.001 g, 0.004 mmol). 
The heterogeneous mixture was stirred at r.t. for 12 h, diluted with water and filtered. The solid  
was dissolved in ethyl acetate, dried (Na2SO4), filtered, concentrated and purified by  
chromatography (SiO2) eluting with hexane-ethyl acetate (1:1) to obtain the triazole 9 (0.054 g, 72%) 
as a white solid: m.p. 158–159 °C; IR (neat) 3559, 2957, 1715, 1613, 1514, 1497, 1247, 1176, 1027, 
1027, 841, 813 cm−1; 1H-NMR (300 MHz, CDCl3) δ 7.74–7.69 (m, 2H), 7.67 (s, 1H), 7.29 (d,  
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J = 8.7 Hz, 2H), 7.10 (app t, J= 8.4 Hz, 2H), 6.91 (d, J = 8.7 Hz, 2H), 4.67–4.54 (m, 3H), 3.82 (s, 3H), 
3.79–3.74 (m, 1H), 2.59 (d, J= 7.2 Hz, 2H), 2.49–2.42 (m, 2H), 2.34–2.26 (m, 2H); 13C-NMR  
(75 MHz, CDCl3) δ 205.7, 164.5, 161.2, 159.8, 147.0, 132.5, 127.6, 127.5, 127.3, 1267.0, 126.9; 
120.1, 116.1, 115.8, 114.3, 78.8, 74.3, 55.5, 49.4, 47.4, 47.0, 36.6; HRMS (ESI) m/z calcd for 
C22H22FN3O3Na (M+Na) 418.1543, found 418.1570.  
 
(2RS,6RS)-2-(4-Methoxyphenyl)-6-(2-(4-(3-methoxyphenyl)-1H-1,2,3-triazol-1-yl)ethyl)dihydro-2H-pyran-
4(3H)-one (10). To a suspension of 3 (0.075 g, 0.272 mmol) and 1-ethynyl-3-methoxybenzene (0.069 
mL, 0.543 mmol) in a mixture of water and tert-butyl alcohol (1:1, 1.5 mL) was added sodium 
ascorbate (0.025 mL, 1 M solution in water), followed by copper(II) sulfate pentahydrate (0.001 g, 
0.004 mmol). The heterogeneous mixture was stirred at r.t. for 12 h, diluted with water, extracted with 
ethyl acetate, dried (Na2SO4), filtered, concentrated and purified by chromatography (SiO2) eluting 
with hexane-ethyl acetate (1:1) to obtain the triazole 10 (0.102 g, 92%) as an off-white solid: m.p. 
111–112 °C; IR (neat) 3633, 2957, 1713, 1611, 1585, 1245, 1174, 1040, 813 cm−1; 1H-NMR  
(300 MHz, CDCl3) δ 7.71 (s, 1H), 7.42–7.41 (m, 1H), 7.34–7.26 (m, 4H), 6.90 (d, J = 8.7 Hz, 2H), 
6.88–6.86 (m, 1H), 4.68–4.53 (m, 3H), 3.86 (s, 3H), 3.81 (s, 3H), 3.77–3.69 (m, 1H), 2.59–2.57  
(d, J = 7.5 Hz, 2H), 2.47–2.41 (m, 2H), 2.33–2.24 (m, 2H); 13C-NMR (75 MHz, CDCl3) δ 205.7, 
160.2, 159.7, 147.7, 132.5, 1312.0, 130.0, 127.3, 120.5, 118.2, 114.4, 114.2, 110.8, 78.7, 74.1, 55.5, 
55.4, 49.3, 47.4, 46.9, 36.6; MS (EI) m/z 430 (M+Na, 90%), 408 (M+H, 60), 365 (70), 233 (15), 215 
(20); HRMS (ESI) m/z calcd for C23H25N3O4Na (M+Na) 430.1743, found 430.1727. 
 
(2RS,6RS)-2-(4-Methoxyphenyl)-6-(2-(4-(pyridin-2-yl)-1H-1,2,3-triazol-1-yl)ethyl)dihydro-2H-pyran-
4(3H)-one (11). To a suspension of 3 (0.080 g, 0.291 mmol) and 2-ethynylpyridine (0.294 mL,  
2.91 mmol) in a mixture of water and tert-butyl alcohol (1:1, 1.6 mL) was added sodium ascorbate 
(0.029 mL, 1 M solution in water), followed by copper(II) sulfate pentahydrate (0.001 g, 0.004 mmol). 
The heterogeneous mixture was stirred at r.t. for 42 h, diluted with water, extracted with ethyl  
acetate, dried (Na2SO4), filtered, concentrated and purified by chromatography (SiO2) eluting with  
hexane-ethyl acetate (3:7) to obtain the triazole 11 (0.095 g, 86%) as a brown oil: IR (neat) 3286, 
2960, 1713, 1605, 1514, 1245, 1174, 1038, 719 cm−1; 1H-NMR (400 MHz, CDCl3) δ 8.56 (app dq,  
J = 0.8, 0.8, 0.8, 4.8 Hz, 1H), 8.14 (app dt, J = 1.2, 1.2, 8.0 Hz, 1H), 8.11 (s, 1H), 7.76 (app dt,  
J = 1.6, 7.6, 7.6 Hz, 1H), 7.31 (d, J = 8.8 Hz, 2H), 7.23 (ddd, J = 1.2, 4.8, 7.6 Hz, 1H), 6.90 (d,  
J = 8.8 Hz, 2H), 4.69–4.54 (m, 3H), 3.81 (s, 1H), 3.79–3.72 (m, 1H), 2.59 (d, J = 7.6 Hz, 2H),  
2.48–2.41 (m, 2H), 2.32–2.27 (m, 2H); 13C-NMR (100 MHz, CDCl3) δ 205.8, 159.7, 150.4, 149.6, 
148.6, 137.1, 132.6, 127.4, 123.1, 122.6, 120.4, 114.2, 78.6, 73.9, 55.5, 49.3, 47.4, 46.9, 36.7; HRMS 
(ESI) m/z calcd for C21H22N4O3Na (M+Na) 401.1590, found 401.1559.  
 
(2RS,6RS)-2-(4-Methoxyphenyl)-6-(2-(4-(pyridin-3-yl)-1H-1,2,3-triazol-1-yl)ethyl)dihydro-2H-pyran-
4(3H)-one (12). To a suspension of 3 (0.087 g, 0.316 mmol) and 3-ethynylpyridine (0.065 g,  
0.630 mmol) in a mixture of water and tert-butyl alcohol (1:1, 1.7 mL) was added sodium ascorbate 
(0.032 mL, 1 M solution in water), followed by copper(II) sulfate pentahydrate (0.001 g, 0.004 mmol). 
The heterogeneous mixture was stirred at r.t. for 14 h, diluted with water and filtered. The solid was 
dissolved in ethyl acetate, dried (Na2SO4), filtered, concentrated and purified by chromatography 
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(SiO2) eluting with hexane-ethyl acetate-triethylamine (1:9:0.1) to obtain the triazole 12 (0.099 g, 
83%) as a brown solid: m.p. 146–147 °C; IR (neat) 2960, 1708, 1611, 1514, 1446, 1247, 1174, 1049, 
1025, 813, 707 cm−1; 1H-NMR (300 MHz, CDCl3) δ 8.92 (dd, J = 0.6, 2.0 Hz, 1H), 8.57 (dd, J = 1.5, 
4.8 Hz, 1H), 8.14 (app dt, J = 1.8, 1.8, 8.3 Hz, 1H) , 7.80 (s, 1H), 7.36 (ddd, J = 0.6, 4.8, 8.1 Hz, 1H), 
7.28 (d, J = 8.4 Hz, 2H), 6.90 (d, J = 8.7 Hz, 2H), 4.73–4.54 (m, 3H), 3.82 (s, 3H), 3.79–3.73 (m, 1H), 
2.59 (d, J= 7.5 Hz, 2H), 2.50–2.43 (m, 2H), 2.39–2.25 (m, 2H); 13C-NMR (100 MHz, CDCl3) δ 205.6, 
159.8, 149.4, 147.2, 144.8, 133.1, 132.5, 127.3, 126.9, 123.9, 120.7, 114.3, 78.9, 74.2, 55.5, 49.4, 47.4, 
47.2, 36.6; HRMS (ESI) m/z calcd for C21H23N4O3 (M+H) 379.1770, found 379.1757.  
 
(2RS,6RS)-2-(4-Methoxyphenyl)-6-(2-(4-(pyridin-4-yl)-1H-1,2,3-triazol-1-yl)ethyl)dihydro-2H-pyran-
4(3H)-one (13). To a suspension of 3 (0.087 g, 0.316 mmol) and 4-ethynylpyridine hydrochloride 
(0.088 g, 0.630 mmol) in a mixture of water and tert-butyl alcohol (1:1, 1.7 mL) was added sodium 
ascorbate (0.032 mL, 1 M solution in water), followed by copper(II) sulfate pentahydrate (0.001 g, 
0.004 mmol). The heterogeneous mixture was stirred at r.t. for 12 h, diluted with water, triethylamine 
(1 mL) was added, extracted with ethyl acetate, dried (Na2SO4), filtered, concentrated and purified by 
chromatography (SiO2) eluting with hexane-ethyl acetate-triethylamine (1:9:0.1). The residue was 
washed with saturated sodium bicarbonate, extracted with ethyl acetate, dried (Na2SO4), filtered and 
concentrated to obtain the triazole 13 (0.034 g, 28%) as an off-white solid: m.p. 144–145 °C; IR (neat) 
3038, 2959, 1715, 1610, 1247, 1213, 746, 719 cm−1; 1H-NMR (400 MHz, CDCl3) δ 8.65 (bs, 2H), 7.85 
(s, 1H), 7.63 (bs, 2H), 7.27 (d, J = 8.4 Hz, 2H), 6.90 (d, J = 8.8 Hz, 2H), 4.73–4.52 (m, 3H), 3.81 (s, 
3H), 3.79–3.74 (m, 1H), 2.59 (d, J = 7.6 Hz, 2H), 2.49–2.40 (m, 2H), 2.35–2.28 (m, 2H); 13C- NMR 
(100 MHz, CDCl3) δ 205.5, 159.8, 150.6, 145.3, 138.1, 132.4, 127.3, 121.9, 114.3, 78.9, 74.4, 55.5, 
49.4, 47.4, 47.3, 36.5, 29.9; HRMS (ESI) m/z calcd for C21H23N4O3 (M+H) 379.1770, found 379.1754. 
 
(2RS,6RS)-2-(4-Methoxyphenyl)-6-(2-(4-(1-methyl-1H-imidazol-5-yl)-1H-1,2,3-triazol-1-yl)ethyl)-
dihydro-2H-pyran-4(3H)-one (14). To a suspension of 3 (0.075 g, 0.272 mmol) and 5-ethynyl-1-
methyl-1H-imidazole (0.056 mL, 0.551 mmol) in a mixture of water and tert-butyl alcohol (1:1,  
1.5 mL) was added sodium ascorbate (0.025 mL, 1 M solution in water), followed by copper(II) sulfate 
pentahydrate (0.001 g, 0.004 mmol). The heterogeneous mixture was stirred at r.t. for 12 h, diluted 
with water, extracted with ethyl acetate, dried (Na2SO4), filtered, concentrated and purified by 
chromatography (SiO2) eluting with chloroform-methanol (20:1) to obtain the triazole 14 (0.090 g, 
87%) as a colorless oil: IR (neat) 3003, 1713, 1610, 1514, 1245, 1174, 1027, 747 cm−1; 1H-NMR  
(300 MHz, CDCl3) δ 7.63 (s, 1H), 7.48 (bs, 1H), 7.27 (d, J = 8.7 Hz, 2H), 7.15 (bs, 1H), 6.89 (d,  
J = 8.7 Hz, 2H), 4.68–4.52 (m, 3H), 3.88 (s, 3H), 3.81 (s, 3H), 3.78–3.67 (m, 1H), 2.58 (d, J = 7.2 Hz, 
2H), 2.48–2.36 (m, 2H), 2.33–2.22 (m, 2H); 13C-NMR (100 MHz, CDCl3) δ 205.6, 159.7, 139.6, 
138.7, 132.4, 128.6, 127.2, 123.5, 121.5, 114.2, 78.7, 74.0, 55.5, 49.3, 47.4, 46.9, 36.5, 33.8; MS (EI) 
m/z 405 (M+Na, 20%), 382 (M+H, 60), 365 (100); HRMS (ESI) m/z calcd for C20H24N5O3 (M+H) 
382.1879, found 382.1854.  
 
(2RS,6RS)-2-(2-(4-(Cyclopentylmethyl)-1H-1,2,3-triazol-1-yl)ethyl)-6-(4-methoxyphenyl)dihydro-2H-
pyran-4(3H)-one (15). To a suspension of 3 (0.072 g, 0.262 mmol) and 3-cyclopentyl-1-propyne 
(0.068 mL, 0.520 mmol) in a mixture of water and tert-butyl alcohol (1:1, 1.1 mL) was added sodium 
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ascorbate (0.025 mL, 1 M solution in water), followed by copper(II) sulfate pentahydrate (0.001 g, 
0.004 mmol). The heterogeneous mixture was stirred at r.t. for 17 h, diluted with water, extracted with 
diethyl ether, dried (Na2SO4), filtered, concentrated and purified by chromatography (SiO2) eluting 
with hexane-ethyl acetate (1:1) to obtain the triazole 15 (0.086 g, 86%) as a colorless oil: IR (neat) 
2945, 1715, 1613, 1514, 1446, 1247, 1174, 1045, 828, 813 cm−1; 1H-NMR (300 MHz, CDCl3) δ 7.29 
(d, J = 8.7 Hz, 2H), 7.22 (s, 1H), 6.92 (d, J = 8.7 Hz, 2H), 4.57–4.49 (m, 3H), 3.82 (s, 3H), 3.73–3.64 
(m, 1H), 2.59 (d, J = 6.0 Hz, 2H), 2.42–2.38 (m, 2H), 2.29–2.06 (m, 3H), 1.78–1.68 (m, 2H),  
1.63–1.51 (m, 4H), 1.25–1.17 (m, 2H); 13C-NMR (100 MHz, CDCl3) δ 205.9, 159.7, 148.0, 132.6, 
127.2, 121.4, 114.2, 78.6, 73.9, 55.5, 49.4, 47.4, 46.4, 40.1, 36.7, 32.6, 31.8, 25.2; HRMS (ESI) m/z 
calcd for C22H29N3O3Na (M+Na) 406.2107, found 406.2069.  
 
(2RS,6RS)-2-(2-(4-Benzyl-1H-1,2,3-triazol-1-yl)ethyl)-6-(4-methoxyphenyl)dihydro-2H-pyran-4(3H)-
one (16). To a suspension of 3 (0.072 g, 0.262 mmol) and 3-phenyl-1-propyne (0.065 mL,  
0.522 mmol) in a mixture of water and tert-butyl alcohol (1:1, 1.1 mL) was added sodium ascorbate 
(0.025 mL, 1 M solution in water), followed by copper(II) sulfate pentahydrate (0.001 g, 0.004 mmol). 
The heterogeneous mixture was stirred at r.t. for 17 h, diluted with water, extracted with diethyl ether, 
dried (Na2SO4), filtered, concentrated and purified by chromatography (SiO2) eluting with hexane-ethyl 
acetate (1:1) to obtain the triazole 16 (0.086 g, 84%) as a colorless oil: IR (neat) 2953, 1713, 1611, 
1514, 1446, 1245, 1174, 1046, 813, 725 cm−1; 1H-NMR (300 MHz, CDCl3) δ 7.33–7.19 (m, 7H), 7.09 
(s, 1H), 6.90 (d, J = 8.7 Hz, 2H), 4.50–4.43 (m, 3H), 4.06 (bs, 2H), 3.82 (s, 3H), 3.68–3.58 (m, 1H), 
2.56 (d, J = 7.5 Hz, 2H), 2.43–2.36 (m, 2H), 2.27–2.13 (m, 2H); 13C-NMR (75 MHz, CDCl3) δ 205.8, 
159.7, 147.9, 139.3, 132.5, 128.9, 128.8, 127.3, 126.7, 122.1, 114.2, 78.6, 73.8, 55.5, 49.2, 47.4, 46.5, 
36.6, 32.4; HRMS (ESI) m/z calcd for C23H25N3O3Na (M+Na) 414.1794, found 414.1768.  
 
(2R,6R)-2-(4-Methoxyphenyl)-6-(2-(4-phenethyl-1H-1,2,3-triazol-1-yl)ethyl)dihydro-2H-pyran-4(3H)-
one (17). To a suspension of 3 (0.072 g, 0.262 mmol) and 4-phenyl-1-butyne (0.074 mL, 0.526 mmol) 
in a mixture of water and tert-butyl alcohol (1:1, 1.1 mL) was added sodium ascorbate (0.025 mL, 1 M 
solution in water), followed by copper(II) sulfate pentahydrate (0.001 g, 0.004 mmol). The 
heterogeneous mixture was stirred at r.t. for 14 h, diluted with water, extracted with diethyl ether, dried 
(Na2SO4), filtered, concentrated and purified by chromatography (SiO2) eluting with hexane-ethyl 
acetate (1:1) to obtain the triazole 17 (0.087 g, 82%) as a colorless oil: IR (neat) 2932, 1717, 1613, 
1515, 1454, 1248, 1177, 1048, 831, 749 cm−1; 1H-NMR (300 MHz, CDCl3) δ 7.29–7.14 (m, 7H), 7.01 
(s, 1H), 6.93 (d, J = 8.7 Hz, 2H), 4.48 (dd, J = 6.2, 7.2 Hz, 2H), 4.38 (dd, J = 5.9, 8.3 Hz, 1H), 3.83 (s, 
3H), 3.52 (m, 1H), 3.09–2.93 (m, 4H), 2.57 (d, J = 5.7 Hz, 2H), 2.39–2.36 (m, 2H), 2.23–2.11 (m, 
2H); 13C-NMR (100 MHz, CDCl3) δ 205.8, 159.7, 147.2, 141.3, 132.6, 128.7, 128.6, 127.3, 126.3, 
121.7, 114.2, 78.4, 73.6, 55.5, 49.3, 47.4, 46.4, 36.6, 35.6, 27.5; HRMS (ESI) m/z calcd for 
C24H27N3O3Na (M+Na) 428.1950, found 428.1982.  
 
(2RS,6RS)-2-(2-(1H-Benzo[d][1,2,3]triazol-1-yl)ethyl)-6-(4-methoxyphenyl)dihydro-2H-pyran-4(3H)-
one (18). To a solution of 3 (0.080 g, 0.291 mmol) in acetonitrile (1.5 mL) was added 18-crown-6 
(0.173 g, 0.654 mmol) and cesium fluoride (0.121 g, 0.797 mmol). The reaction mixture was stirred at 
r.t. for 15 min and 2-(trimethylsilyl)phenyl trifluoromethanesulfonate (0.194 mL, 0.798 mmol) in 
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acetonitrile (1 mL) was added. The reaction mixture was stirred at r.t. for 2 h, quenched with saturated 
sodium bicarbonate solution, extracted with diethyl ether, dried (Na2SO4), filtered, concentrated and 
purified by chromatography (SiO2) eluting with hexane-ethyl acetate (3:2) to obtain the triazole 18 
(0.080 g, 78%) as a white solid: m.p. 137–138 °C; IR (neat) 2954, 1717, 1612, 1514, 1446, 1303, 
1247, 1174, 1049, 1027, 813, 747 cm−1; 1H-NMR (300 MHz, CDCl3) δ 8.05 (dd, J = 1.8, 6.9 Hz, 1H),  
7.44–7.27 (m, 3H), 7.31 (d, J = 8.7 Hz, 2H), 6.96 (d, J = 8.7 Hz, 2H), 4.89–4.77 (m, 2H), 4.43 (dd,  
J = 4.9, 9.4 Hz, 1H), 3.85 (s, 3H), 3.61–3.50 (m, 1H), 2.58–2.55 (m, 2H), 2.41–2.32 (m, 4H);  
13C- NMR (100 MHz, CDCl3) δ 205.7, 159.7, 145.9, 133.5, 132.8, 127.5, 127.3, 124.1, 120.2, 114.3, 
109.5, 78.7, 73.7, 55.5, 49.6, 47.5, 44.1, 36.5; MS (EI) m/z 374 (M+Na, 40%), 365 (100); HRMS  
(ESI) m/z calcd for C20H21N3O3Na (M+Na) 374.1481, found 374.1450.  
(2RS,6RS)-2-(2-(1H-Pyrazol-1-yl)ethyl)-6-(4-methoxyphenyl)dihydro-2H-pyran-4(3H)-one (19). To a 
solution of alcohol intermediate (0.091 g, 0.364 mmol), triethylamine (0.076 mL, 0.546 mmol) and 
DMAP (0.002 g, 0.016 mmol) in DCM (2 mL) was added methane sulfonyl chloride (0.034 mL,  
0.437 mmol) dropwise at 0 °C. The resulting solution was stirred for 15 min, diluted with HCl (0.5 M) 
and extracted with DCM. The aqueous layer was back extracted with DCM, and the combined organic 
layers were washed with saturated sodium bicarbonate and brine. The organic layer was dried 
(Na2SO4), filtered and concentrated to obtain crude 2-((2R,6R)-6-(4-methoxyphenyl)-4-oxotetrahydro-
2H-pyran-2-yl)ethyl methanesulfonate 2a (0.120 g, quant.) as a yellow oil which was used without 
further purification. Pyrazole (0.029 g, 0.426 mmol) in DMF (1 mL) was added to a slurry of sodium 
hydride (0.013 g, 0.542 mmol) in DMF (3 mL) and stirred for 2 h. The resulting solution was added 
dropwise to a solution of the mesylate 2a (0.120 g, 0.365 mmol) in DMF (0.5 mL) at 0 °C. The 
reaction mixture was stirred at 0 °C for 5 h, diluted with water, extracted with diethyl ether, dried 
(Na2SO4), filtered, concentrated, and purified by chromatography (SiO2) eluting with hexane-ethyl 
acetate (7:3) to afford 19 (0.022 g, 20% over two steps) as a colorless oil: IR (neat) 2956, 1713, 1514, 
1247, 1027, 906, 725 cm−1; 1H-NMR (300 MHz, CDCl3) δ 7.52 (d, J = 1.5 Hz, 1H), 7.34–7.31 (m, 
3H), 6.95 (d, J = 8.7 Hz, 2H), 6.22 (t, J = 1.8 Hz, 1H), 4.54 (dd, J = 5.4, 8.7 Hz, 1H), 4.34 (dd, J = 5.7, 
7.8 Hz, 1H), 3.84 (s, 3H), 3.64–3.55 (m, 1H), 2.63–2.52 (m, 2H), 2.44–2.37 (m, 2H), 2.33–2.13 (m, 
2H); 13C-NMR (100 MHz, CDCl3) δ 206.4, 159.7, 139.8, 132.9, 129.7, 127.2, 114.2, 105.5, 78.5, 74.1, 
55.5, 49.5, 48.2, 47.6, 36.8; HRMS (ESI) m/z calcd for C17H20N2O3 300.1474, found 300.1468. 
(2RS,4SR,6RS)-2-(4-Methoxyphenyl)-6-(2-(4-phenyl-1H-1,2,3-triazol-1-yl)ethyl)tetrahydro-2H-pyran-
4-ol (20). To a solution of 4 (0.040 g, 0.106 mmol) in MeOH (5 mL) at −10 °C was added NaBH4 
(0.002 g, 0.053 mmol) in one portion. The reaction mixture was stirred at −10 °C for 4 h, quenched 
with water (2 drops), concentrated, purified by chromatography (SiO2) eluting with hexane-ethyl 
acetate (1:1) to afford 20 (0.023 g, 72%-based on recovered 4, 0.008 g) as an off-white solid: m.p. 
139–140 °C; IR (neat) 3430, 2917, 1612, 1514, 1446, 1174, 1075, 1027, 701 cm−1; 1H-NMR (600 MHz, 
CDCl3) δ 7.78 (d, J = 7.2 Hz, 2H), 7.72 (s, 1H), 7.42 (t, J = 7.2 Hz, 2H), 7.33 (t, J = 7.2 Hz, 1H), 7.29 
(d, J = 8.4 Hz, 2H), 6.89 (d, J = 8.4 Hz, 2H), 4.62–4.52 (m, 2H), 4.28 (dd, J = 1.8, 11.4 Hz, 1H),  
3.96–3.91 (m, 1H), 3.82 (s, 3H), 3.45–3.42 (m, 1H), 2.28-2.23 (m, 1H), 2.19–2.13 (m, 2H), 2.02–1.99 
(m, 1H), 1.88 (bs, 1H), 1.53 (ap q, J = 10.8 Hz, 1H), 1.35 (ap q, J = 11.0 Hz, 1H); 13C-NMR  
(100 MHz, CDCl3) δ 159.4, 147.7, 133.9, 130.9, 129.0, 128.3, 127.5, 125.9, 120.5, 114.1, 72.7, 68.3, 
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55.5, 47.1, 42.7, 40.9, 36.4; HRMS (ESI) m/z calcd for C22H25N3O3Na (M+Na) 402.1794, found 
402.1766. 
 
(2RS,4RS,6RS)-2-(4-Methoxyphenyl)-6-(2-(4-phenyl-1H-1,2,3-triazol-1-yl)ethyl)tetrahydro-2H-pyran-
4-ol (21). To a solution of 4 (0.050 g, 0.132 mmol) in THF (5.5 mL) at −90 °C was added L-Selectride 
(0.199 mL, 1 M in THF) dropwise over 10 min. The reaction mixture was stirred at −90 °C for 15 min, 
and quenched with saturated potassium sodium tartrate (10 mL). The mixture was diluted with diethyl 
ether (10 mL), stirred for 1 h, extracted with diethyl ether, concentrated, and purified by 
chromatography (SiO2) eluting with hexane-ethyl acetate (1:1) to give 21 (0.046 g, 92%) as an  
off-white solid: m.p. 127–128 °C; IR (neat) 3485, 2952, 1724, 1609, 1512, 1463, 1297, 1236, 1174, 
1081, 1046, 826 cm−1; 1H-NMR (600 MHz, CDCl3) δ 7.76 (d, J = 7.2 Hz, 2H), 7.73 (s, 1H), 7.41 (t,  
J = 7.8 Hz, 2H), 7.34–7.31 (m, 1H), 7.29 (d, J = 8.4 Hz, 2H), 6.89 (d, J = 8.4 Hz, 2H), 4.80 (dd,  
J = 1.8, 12.0 Hz, 1H), 4.57–4.55 (m, 2H), 4.35–4.34 (m, 1H), 3.99–3.95 (m, 1H), 3.81 (s, 3H), 2.18 
(bs, 1H), 2.21–2.15 (m, 1H), 2.11–2.05 (m, 1H), 1.91–1.89 (m, 1H), 1.78 (ddd, J = 2.6, 11.9, 14.2 Hz, 
1H), 1.73 (dd, J = 2.3, 13.9 Hz, 1H), 1.62 (ddd, J = 3.0, 3.0, 12.0 Hz, 1H); 13C-NMR (100 MHz, 
CDCl3) δ 159.2, 147.7, 134.9, 130.9, 128.9, 128.2, 127.5, 125.9, 120.6, 114.0, 73.6, 69.3, 64.8, 55.5, 
47.3, 40.4, 38.4, 36.6; HRMS (ESI) m/z calcd for C22H25N3O3Na (M+Na) 402.1794, found 402.1798. 
4. Conclusions  
In conclusion, a structurally diverse library of 2,6-disubstituted tetrahydropyrans featuring the 
DDQ-mediated C-H activation reaction has been developed. Most of the tetrahydropyrans were 
modified at the side chains via a click chemistry reaction to introduce substituted triazoles 4-17. 
Several additional heterocyclic derivatives were also prepared. Diversity analysis showed that this 
library occupied unique chemical space compared to a 5 million “drug-like” compound collection as 
measured by the Tanimoto metric. The biological evaluation of this tetrahydropyran-based screening 
library is currently in progress.  
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